Interactions of neuroimmune signaling and glutamate plasticity in addiction
- PMID: 33612110
- PMCID: PMC7897396
- DOI: 10.1186/s12974-021-02072-8
Interactions of neuroimmune signaling and glutamate plasticity in addiction
Abstract
Chronic use of drugs of abuse affects neuroimmune signaling; however, there are still many open questions regarding the interactions between neuroimmune mechanisms and substance use disorders (SUDs). Further, chronic use of drugs of abuse can induce glutamatergic changes in the brain, but the relationship between the glutamate system and neuroimmune signaling in addiction is not well understood. Therefore, the purpose of this review is to bring into focus the role of neuroimmune signaling and its interactions with the glutamate system following chronic drug use, and how this may guide pharmacotherapeutic treatment strategies for SUDs. In this review, we first describe neuroimmune mechanisms that may be linked to aberrant glutamate signaling in addiction. We focus specifically on the nuclear factor-kappa B (NF-κB) pathway, a potentially important neuroimmune mechanism that may be a key player in driving drug-seeking behavior. We highlight the importance of astroglial-microglial crosstalk, and how this interacts with known glutamatergic dysregulations in addiction. Then, we describe the importance of studying non-neuronal cells with unprecedented precision because understanding structure-function relationships in these cells is critical in understanding their role in addiction neurobiology. Here we propose a working model of neuroimmune-glutamate interactions that underlie drug use motivation, which we argue may aid strategies for small molecule drug development to treat substance use disorders. Together, the synthesis of this review shows that interactions between glutamate and neuroimmune signaling may play an important and understudied role in addiction processes and may be critical in developing more efficacious pharmacotherapies to treat SUDs.
Keywords: Addiction; Astroglia; Glutamate; Microglia; Neuroimmune.
Conflict of interest statement
We have no conflicts of interest to declare.
Figures


Similar articles
-
Induction of innate immune genes in brain create the neurobiology of addiction.Brain Behav Immun. 2011 Jun;25 Suppl 1(Suppl 1):S4-S12. doi: 10.1016/j.bbi.2011.03.003. Epub 2011 Mar 21. Brain Behav Immun. 2011. PMID: 21402143 Free PMC article. Review.
-
Glial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse.Neuropsychopharmacology. 2017 Jan;42(1):156-177. doi: 10.1038/npp.2016.121. Epub 2016 Jul 11. Neuropsychopharmacology. 2017. PMID: 27402494 Free PMC article. Review.
-
Contributions of neuroimmune and gut-brain signaling to vulnerability of developing substance use disorders.Neuropharmacology. 2021 Jul 1;192:108598. doi: 10.1016/j.neuropharm.2021.108598. Epub 2021 May 6. Neuropharmacology. 2021. PMID: 33965398 Free PMC article. Review.
-
Toll-like receptor signaling and stages of addiction.Psychopharmacology (Berl). 2017 May;234(9-10):1483-1498. doi: 10.1007/s00213-017-4560-6. Epub 2017 Feb 17. Psychopharmacology (Berl). 2017. PMID: 28210782 Free PMC article. Review.
-
The good and bad news about glutamate in drug addiction.J Psychopharmacol. 2016 Nov;30(11):1095-1098. doi: 10.1177/0269881116655248. Epub 2016 Jun 28. J Psychopharmacol. 2016. PMID: 27353027 Free PMC article. Review.
Cited by
-
Multi-chemokine receptor antagonist RAP-103 inhibits opioid-derived respiratory depression, reduces opioid reinforcement and physical dependence, and normalizes opioid-induced dysregulation of mesolimbic chemokine receptors in rats.Drug Alcohol Depend. 2022 Sep 1;238:109556. doi: 10.1016/j.drugalcdep.2022.109556. Epub 2022 Jul 11. Drug Alcohol Depend. 2022. PMID: 35843139 Free PMC article.
-
Neuroscience and addiction research: current advances and perspectives.J Neural Transm (Vienna). 2024 May;131(5):405-408. doi: 10.1007/s00702-024-02763-5. Epub 2024 Mar 16. J Neural Transm (Vienna). 2024. PMID: 38492013 No abstract available.
-
Divergent gene expression patterns in alcohol and opioid use disorders lead to consistent alterations in functional networks within the dorsolateral prefrontal cortex.Transl Psychiatry. 2024 Oct 14;14(1):437. doi: 10.1038/s41398-024-03143-z. Transl Psychiatry. 2024. PMID: 39402051 Free PMC article.
-
Nicotinic regulation of microglia: potential contributions to addiction.J Neural Transm (Vienna). 2024 May;131(5):425-435. doi: 10.1007/s00702-023-02703-9. Epub 2023 Oct 1. J Neural Transm (Vienna). 2024. PMID: 37778006 Free PMC article. Review.
-
Faecal Microbiota Transplantation Modulates Morphine Addictive-Like Behaviours Through Hippocampal Metaplasticity.Addict Biol. 2025 Apr;30(4):e70034. doi: 10.1111/adb.70034. Addict Biol. 2025. PMID: 40237231 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
- DA044479/DA/NIDA NIH HHS/United States
- F32 DA050427/DA/NIDA NIH HHS/United States
- DA036569/DA/NIDA NIH HHS/United States
- DA047269/DA/NIDA NIH HHS/United States
- DA050427/DA/NIDA NIH HHS/United States
- R01 DA046526/DA/NIDA NIH HHS/United States
- R01 DA045499/DA/NIDA NIH HHS/United States
- R33 DA049130/DA/NIDA NIH HHS/United States
- DA040004/DA/NIDA NIH HHS/United States
- R01 DA039139/DA/NIDA NIH HHS/United States
- R01 DA051205/DA/NIDA NIH HHS/United States
- UL1 TR001450/TR/NCATS NIH HHS/United States
- DA039139/DA/NIDA NIH HHS/United States
- DA046526/DA/NIDA NIH HHS/United States
- R00 DA040004/DA/NIDA NIH HHS/United States
- DA045881/DA/NIDA NIH HHS/United States
- R21 DA049130/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical